Shenglan Yang
State Key Laboratory Of Ophthalmology, Guangdong Provincial Key Laboratory Of Ophthalmology And Visual Science
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
GSDMD mediated pyroptosis induced inflammation of Graves' orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway.
Journal: Experimental eye research
Published: September 14, 2023
HbA1c: an independent risk factor for dysthyroid optic neuropathy.
Journal: Frontiers in endocrinology
Published: July 01, 2023
Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy.
Journal: International journal of molecular sciences
Published: October 21, 2022
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
Journal: International journal of molecular sciences
Published: April 06, 2022
Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
Journal: Frontiers in endocrinology
Published: March 08, 2022
Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 04, 2021
Increased Dysfunctional and Plastic Regulatory T Cells in Idiopathic Orbital Inflammation.
Journal: Frontiers in immunology
Published: November 29, 2020
Tear cytokine profiles in patients with extranodal marginal zone B-cell lymphoma of the ocular adnexa.
Journal: Eye (London, England)
Published: November 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026